Back
Credit Acceptance Vs. Viking Therapeutics Industry Stock Comparison
Buy
59
CACC
Credit Acceptance
Last Price:
449.00
Seasonality Move:
3.66%
Buy
58
VKTX
Viking Therapeutics
Last Price:
61.63
Seasonality Move:
36.82%
Buy
59
Credit Acceptance (CACC)
is a Buy
Is Credit Acceptance a Buy, Sell or Hold?
- The current Credit Acceptance [CACC] share price is $447.69. The Score for CACC is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- CACC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $61.63. The Score for VKTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CACC Stock Price Chart
What is Credit Acceptance's stock price today?
-
The Credit Acceptance share price today is $447.69
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CACC is experiencing slight buying pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $61.63
The current trend is moderately bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
CACC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.95 | Sell |
Relative Strength Index (14 RSI): | 46.57 | Sell |
Chaikin Money Flow: | 4930 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (434.21 - 467.51) | Sell |
Bollinger Bands (100): | (448.51 - 536.49) | Sell |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.12 | Buy |
Relative Strength Index (14 RSI): | 49.26 | Sell |
Chaikin Money Flow: | -1176939 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (57.9 - 66.32) | Sell |
Bollinger Bands (100): | (52.14 - 66.8) | Buy |
CACC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 449.87 | Sell |
20-day SMA: | 444.73 | Buy |
50-day SMA: | 476.33 | Sell |
200-day SMA: | 516.43 | Sell |
8-day EMA: | 445.97 | Buy |
20-day EMA: | 449.57 | Sell |
50-day EMA: | 468.35 | Sell |
200-day EMA: | 496.2 | Sell |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.66 | Sell |
20-day SMA: | 61.87 | Sell |
50-day SMA: | 59.76 | Buy |
200-day SMA: | 53.91 | Buy |
8-day EMA: | 63.35 | Sell |
20-day EMA: | 62.66 | Sell |
50-day EMA: | 60.77 | Buy |
200-day EMA: | 52.02 | Buy |
Credit Acceptance Earnings Growth & CACC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.31 per share, an increase next quarter of $1.45 per share, a decrease this year of $0.94 per share, and an increase next year of $3.36 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
Credit Acceptance Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |